Concepedia

Mira Tout

MT

Statistics

Publications

3

Citations

144

H-Index

3

Active since

2016

Affiliations

Centre Hospitalier Universitaire de Tours(Current)

Centre National de la Recherche Scientifique

Université de Tours

Inserm

Centre Hospitalier Universitaire d'Angers

Mira Tout is an author at Centre Hospitalier Universitaire de Tours specializing in cancer immunology, rituximab-based therapy, and oncology.

Publications per year

2016–2017

3

Publications

3

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report

Mira Tout, Olivier Casasnovas, Michel Meignan et al. · Blood · 2017 · 93 citations · Full text

, , +8

Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antigen Count on Target-Mediated Elimination of Rituximab in Patients with Chronic Lymphocytic Leukemia: A Study of FILO Group

Mira Tout, Anne-Laure Gagez, Stéphane Leprêtre et al. · Clinical Pharmacokinetics · 2016 · 27 citations

, , +11

A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen

Emilie Lereclus, Mira Tout, Alban Girault et al. · BMC Cancer · 2017 · 24 citations · Full text

, , +13

1–3 of 3